Annual Accounts Payable
$2.42 M
+$265.00 K+12.27%
December 31, 2023
Summary
- As of February 7, 2025, JANX annual accounts payable is $2.42 million, with the most recent change of +$265.00 thousand (+12.27%) on December 31, 2023.
- During the last 3 years, JANX annual accounts payable has risen by +$2.00 million (+466.36%).
- JANX annual accounts payable is now -1.38% below its all-time high of $2.46 million, reached on December 31, 2021.
Performance
JANX Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$2.46 M
+$1.21 M+96.49%
September 30, 2024
Summary
- As of February 7, 2025, JANX quarterly accounts payable is $2.46 million, with the most recent change of +$1.21 million (+96.49%) on September 30, 2024.
- Over the past year, JANX quarterly accounts payable has dropped by -$43.00 thousand (-1.72%).
- JANX quarterly accounts payable is now -31.86% below its all-time high of $3.61 million, reached on September 30, 2021.
Performance
JANX Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
JANX Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +12.3% | -1.7% |
| 3 y3 years | +466.4% | -31.9% |
| 5 y5 years | +807.9% | - |
JANX Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -1.4% | +12.3% | -17.9% | +96.5% |
| 5 y | 5-year | -1.4% | +807.9% | -31.9% | +595.5% |
| alltime | all time | -1.4% | +807.9% | -31.9% | +595.5% |
Janux Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $2.46 M(+96.5%) |
| Jun 2024 | - | $1.25 M(-44.4%) |
| Mar 2024 | - | $2.25 M(-7.0%) |
| Dec 2023 | $2.42 M(+12.3%) | $2.42 M(-3.2%) |
| Sep 2023 | - | $2.50 M(+31.2%) |
| Jun 2023 | - | $1.91 M(-6.9%) |
| Mar 2023 | - | $2.05 M(-5.0%) |
| Dec 2022 | $2.16 M | $2.16 M(-24.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $2.87 M(-4.5%) |
| Jun 2022 | - | $3.00 M(+54.7%) |
| Mar 2022 | - | $1.94 M(-21.1%) |
| Dec 2021 | $2.46 M(+474.3%) | $2.46 M(-32.0%) |
| Sep 2021 | - | $3.61 M(+920.6%) |
| Jun 2021 | - | $354.00 K(-58.7%) |
| Mar 2021 | - | $857.00 K(+100.2%) |
| Dec 2020 | $428.00 K(+60.3%) | $428.00 K |
| Dec 2019 | $267.00 K | - |
FAQ
- What is Janux Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Janux Therapeutics?
- What is Janux Therapeutics annual accounts payable year-on-year change?
- What is Janux Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Janux Therapeutics?
- What is Janux Therapeutics quarterly accounts payable year-on-year change?
What is Janux Therapeutics annual accounts payable?
The current annual accounts payable of JANX is $2.42 M
What is the all time high annual accounts payable for Janux Therapeutics?
Janux Therapeutics all-time high annual accounts payable is $2.46 M
What is Janux Therapeutics annual accounts payable year-on-year change?
Over the past year, JANX annual accounts payable has changed by +$265.00 K (+12.27%)
What is Janux Therapeutics quarterly accounts payable?
The current quarterly accounts payable of JANX is $2.46 M
What is the all time high quarterly accounts payable for Janux Therapeutics?
Janux Therapeutics all-time high quarterly accounts payable is $3.61 M
What is Janux Therapeutics quarterly accounts payable year-on-year change?
Over the past year, JANX quarterly accounts payable has changed by -$43.00 K (-1.72%)